Gaceta Medica de Bilbao最新文献

筛选
英文 中文
Embolización de malformación arteriovenosa pulmonar con Amplatzer®. A propósito de un caso Amplatzer®肺动静脉畸形栓塞。关于一个案例
Gaceta Medica de Bilbao Pub Date : 2011-10-01 DOI: 10.1016/j.gmb.2011.08.003
Naroa Serrano-Usaola, José Javier Echevarría-Uraga, José Luis Miguelez-Vidales, Karmele Armendáriz-Tellitu
{"title":"Embolización de malformación arteriovenosa pulmonar con Amplatzer®. A propósito de un caso","authors":"Naroa Serrano-Usaola,&nbsp;José Javier Echevarría-Uraga,&nbsp;José Luis Miguelez-Vidales,&nbsp;Karmele Armendáriz-Tellitu","doi":"10.1016/j.gmb.2011.08.003","DOIUrl":"10.1016/j.gmb.2011.08.003","url":null,"abstract":"<div><p>Pulmonary arteriovenous malformations are a rare clinical entity. Most are congenital and asymptomatic but some can cause dyspnea, hypoxemia, hemoptysis, and even more severe complications such as neurological and cardiovascular complications. Endovascular embolization with coils or detachable balloons has shown high therapeutic efficacy but is not exempt from possible complications due to distal migration of these devices. To avoid these adverse events, new devices have been designed with various mechanisms to prevent their migration. We report the case of a large solitary pulmonary arteriovenous malformation successfully treated with an Amplatzer<sup>®</sup> device.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 4","pages":"Pages 123-126"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.08.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Manejo de los accesos vasculares para hemodiálisis 血液透析血管通路的管理
Gaceta Medica de Bilbao Pub Date : 2011-10-01 DOI: 10.1016/j.gmb.2011.09.001
Ángel Barba-Vélez , Julen Ocharan-Corcuera , Andreu Foraster
{"title":"Manejo de los accesos vasculares para hemodiálisis","authors":"Ángel Barba-Vélez ,&nbsp;Julen Ocharan-Corcuera ,&nbsp;Andreu Foraster","doi":"10.1016/j.gmb.2011.09.001","DOIUrl":"10.1016/j.gmb.2011.09.001","url":null,"abstract":"<div><p>Vascular access for hemodialysis is of the utmost importance for all patients undergoing this dialysis technique, posing the need for all the specialists involved to coordinate in order to provide each patient with the best solution and possible alternatives (vascular surgery, angiologists, nephrology nurses). The present article evaluates the optimal type vascular access. The distinct approaches to the most common problems of vascular access in the predialysis and dialysis phases are analyzed, considering the three possibilities: arteriovenous fistula, prosthesis and venous catheter.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 4","pages":"Pages 108-113"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Meningitis fulminante por Streptococcus pyogenes 暴发性脑膜炎化脓性链球菌
Gaceta Medica de Bilbao Pub Date : 2011-10-01 DOI: 10.1016/j.gmb.2011.05.002
Carmen Mateo Revilla , Beatriz Santamaría Roqueiro , Tomas Rodríguez Delgado , Ana Manzano Canalaechevarria , Juan José Gómez Sainz , Luciano Aguilera Celorrio
{"title":"Meningitis fulminante por Streptococcus pyogenes","authors":"Carmen Mateo Revilla ,&nbsp;Beatriz Santamaría Roqueiro ,&nbsp;Tomas Rodríguez Delgado ,&nbsp;Ana Manzano Canalaechevarria ,&nbsp;Juan José Gómez Sainz ,&nbsp;Luciano Aguilera Celorrio","doi":"10.1016/j.gmb.2011.05.002","DOIUrl":"10.1016/j.gmb.2011.05.002","url":null,"abstract":"<div><p><em>Streptococcus pyogenes</em>, or group A <em>Streptococcus</em>, rarely causes bacterial meningitis in adults but has a high mortality rate if untreated. This bacterium has become more aggressive and shows greater invasive capacity, increasing the incidence and severity of infections. These observations have led to the hypothesis of a more virulent strain.</p><p>We report the case of a healthy 54-year-old woman with neck pain and rapid neurological and hemodynamic worsening despite appropriate antibiotic and corticosteroid treatment who died 5<!--> <!-->hours after admission.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 4","pages":"Pages 114-116"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sociodemographic characteristics by primary cancer diagnosis of patients dying in a palliative care unit: A retrospective analysis 在姑息治疗病房死亡的患者的原发癌症诊断的社会人口学特征:回顾性分析
Gaceta Medica de Bilbao Pub Date : 2011-10-01 DOI: 10.1016/j.gmb.2011.08.002
Gema Costa-Requena , Betlem Cervelló , Ramon Cristófol , José Cañete
{"title":"Sociodemographic characteristics by primary cancer diagnosis of patients dying in a palliative care unit: A retrospective analysis","authors":"Gema Costa-Requena ,&nbsp;Betlem Cervelló ,&nbsp;Ramon Cristófol ,&nbsp;José Cañete","doi":"10.1016/j.gmb.2011.08.002","DOIUrl":"10.1016/j.gmb.2011.08.002","url":null,"abstract":"<div><h3>Background</h3><p>To identify the resources that could improve the care of patients with advanced disease, the present study describes the sociodemographic characteristics of advanced cancer patients dying in a palliative care unit.</p></div><div><h3>Method</h3><p>We performed a retrospective study of oncology patients who died in a palliative care unit from January 2006 to December 2009. A descriptive analysis was conducted to compare the clinical and sociodemographic characteristics of advanced cancer patients, using measures of central tendency and frequencies.</p></div><div><h3>Results</h3><p><span>Of the total number of oncology patients, 443 died in the palliative care unit. The most frequent primary cancer site was the lung (20.5%), followed by the liver–pancreas (17.2%), and genitourinary apparatus (16.5%). The primary cancer diagnosis was significantly related to gender (</span><em>χ</em><sup>2</sup> <!-->=<!--> <!-->55.97, <em>p</em> <!-->&lt;<!--> <!-->0.00). The primary cancer diagnosis in younger patients was respiratory tumor. When gender was considered, men with a cancer diagnosis were significantly younger than women (<em>Z</em> <!-->=<!--> <!-->−2.19, <em>p</em> <!-->=<!--> <!-->0.028). No significant differences in the length of admission were identified on comparing means according to the primary cancer diagnosis (<em>χ</em><sup>2</sup> <!-->=<!--> <!-->9.77, <em>p</em> <!-->=<!--> <!-->0.36), gender (<em>Z</em> <!-->=<!--> <!-->−0.3, <em>p</em> <!-->=<!--> <!-->0.76) or age groups (<em>χ</em><sup>2</sup> <!-->=<!--> <!-->5.29, <em>p</em> <!-->=<!--> <!-->0.15).</p></div><div><h3>Conclusions</h3><p>Among patients with advanced cancer who died in the palliative care unit, significant demographic variables were gender and age.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 4","pages":"Pages 101-107"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La Ley General de Sanidad cumple 25 años con un balance positivo 《一般卫生法》迎来了25年的积极平衡
Gaceta Medica de Bilbao Pub Date : 2011-10-01 DOI: 10.1016/j.gmb.2011.10.001
Leire Pajín-Iraola
{"title":"La Ley General de Sanidad cumple 25 años con un balance positivo","authors":"Leire Pajín-Iraola","doi":"10.1016/j.gmb.2011.10.001","DOIUrl":"10.1016/j.gmb.2011.10.001","url":null,"abstract":"","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 4","pages":"Pages 99-100"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.10.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78274760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discurso de ingreso en la Real Academia de Medicina del País Vasco: La enfermedad tuberculosa al inicio del siglo xxi 在巴斯克地区皇家医学院的就职演说:21世纪初的结核病
Gaceta Medica de Bilbao Pub Date : 2011-07-01 DOI: 10.1016/j.gmb.2011.06.003
Ricardo Franco Vicario
{"title":"Discurso de ingreso en la Real Academia de Medicina del País Vasco: La enfermedad tuberculosa al inicio del siglo xxi","authors":"Ricardo Franco Vicario","doi":"10.1016/j.gmb.2011.06.003","DOIUrl":"10.1016/j.gmb.2011.06.003","url":null,"abstract":"","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 3","pages":"Pages 81-93"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.06.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El sida, 30 años después: una epidemia de prejuicios 艾滋病,30年后:偏见的流行
Gaceta Medica de Bilbao Pub Date : 2011-07-01 DOI: 10.1016/j.gmb.2011.06.001
Ricardo Franco-Vicario
{"title":"El sida, 30 años después: una epidemia de prejuicios","authors":"Ricardo Franco-Vicario","doi":"10.1016/j.gmb.2011.06.001","DOIUrl":"https://doi.org/10.1016/j.gmb.2011.06.001","url":null,"abstract":"","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 3","pages":"Pages 66-67"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91710215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estudio de los niveles de ligando CD40 en pacientes con síndrome coronario agudo 急性冠状动脉综合征患者CD40配体水平的研究
Gaceta Medica de Bilbao Pub Date : 2011-07-01 DOI: 10.1016/j.gmb.2011.05.003
Ángel San Miguel Hernández , Blanca Martin Armentia , Alicia Armentia Medina , José Manuel Rodriguez Valencia
{"title":"Estudio de los niveles de ligando CD40 en pacientes con síndrome coronario agudo","authors":"Ángel San Miguel Hernández ,&nbsp;Blanca Martin Armentia ,&nbsp;Alicia Armentia Medina ,&nbsp;José Manuel Rodriguez Valencia","doi":"10.1016/j.gmb.2011.05.003","DOIUrl":"10.1016/j.gmb.2011.05.003","url":null,"abstract":"<div><h3>Introduction</h3><p>The CD40 ligand (CD40L) is a member of the tumor necrosis factor superfamily and plays an important role in the regulation of thymus-dependent humoral immunity and cell-mediated immune responses. This ligand is a 39 kDa, 261 amino acid (aa) glycoprotein that can form either homotrimers or undergo proteolytic cleavage to produce soluble forms of CD40 (i.e. 15-18 KDa). Elevated levels of soluble CD40L (sCD40L) have been observed in the sera of patients with systemic lupus erythematosus, chronic lymphocytic leukemia and unstable angina. Enhanced levels of both soluble and membrane-bound CD40L in angina patients suggest that CD40L plays a pathogenic role in the atherosclerotic process and in promoting acute coronary syndromes (ACS).</p></div><div><h3>Material and methods</h3><p>We analyzed serum sCD40L levels in 56 patients with ACS (aged 54.4<!--> <!-->±<!--> <!-->13.4 years) from the internal medicine department of our hospital compared with levels in 22 healthy controls (aged 43<!--> <!-->±<!--> <!-->8 years). To measure sCD40 we used the Quantikine CD40 ligand immunoassay, a solid-phase ELISA designed to measure human CD40 in serum using <em>E. coli</em>-expressed recombinant human CD40. For comparison purposes, troponin T data was measured in patients with ACS. These data were obtained by a chemiluminescent method using the Elecsys 2100 Roche Diagnostics analyzer.</p></div><div><h3>Results</h3><p>Mean values of CD40L were significantly higher in healthy controls (546.7<!--> <!-->±<!--> <!-->64.7 pg/mL) than in ACS patients: 1,048<!--> <!-->±<!--> <!-->157 pg/mL (p<!--> <!-->&lt;<!--> <!-->0.05). The comparison study between troponin T and CD40L generated the following regression equation: Troponin T<!--> <!-->=<!--> <!-->1.48 * CD40L - 0.004.</p></div><div><h3>Discussion</h3><p>The proinflammatory and procoagulant protein CD40L represents a novel target in the treatment of atherosclerosis and ACS. Currently, risk evaluation in patients with ACS can be carried out by troponin analysis. Although troponins are only markers of myocardial necrosis, sCD40L is a marker of platelet activation and unstable plaques and can thus be used to identify disease activity before the development of cardiac cell necrosis.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 3","pages":"Pages 75-80"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54324399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Termocoagulación mediante radiofrecuencia en el tratamiento de la neuralgia del trigémino. Descripción de la técnica y experiencia en el Hospital Universitario de Cruces a lo largo de 10 años 射频热凝在三叉神经痛治疗中的应用。描述在克鲁塞斯大学医院超过10年的技术和经验
Gaceta Medica de Bilbao Pub Date : 2011-07-01 DOI: 10.1016/j.gmb.2011.05.001
José Undabeitia , J.M. Dmetrichuk , J.J. Aurrecoechea , G. Catalan , E. Ruiz de Gopegui , L. Galbarriatu , G. Bilbao , I. Hernandez , J. Iglesias , G. Carbayo , M. Canales , A. Igartua , I. Pomposo
{"title":"Termocoagulación mediante radiofrecuencia en el tratamiento de la neuralgia del trigémino. Descripción de la técnica y experiencia en el Hospital Universitario de Cruces a lo largo de 10 años","authors":"José Undabeitia ,&nbsp;J.M. Dmetrichuk ,&nbsp;J.J. Aurrecoechea ,&nbsp;G. Catalan ,&nbsp;E. Ruiz de Gopegui ,&nbsp;L. Galbarriatu ,&nbsp;G. Bilbao ,&nbsp;I. Hernandez ,&nbsp;J. Iglesias ,&nbsp;G. Carbayo ,&nbsp;M. Canales ,&nbsp;A. Igartua ,&nbsp;I. Pomposo","doi":"10.1016/j.gmb.2011.05.001","DOIUrl":"https://doi.org/10.1016/j.gmb.2011.05.001","url":null,"abstract":"<div><h3>Objectives</h3><p>The incidence of trigeminal neuralgia is 4-5 cases/100,000 inhabitants per year<em>.</em> This disorder causes substantial morbidity in affected individuals. Identifying the factors associated with optimal detection and treatment of this disorder is essential. In this article, we describe our experience with trigeminal neuralgia in a 10-year period.</p></div><div><h3>Methods</h3><p>Our hospital database was searched and patients who were treated with radiofrequency thermo-coagulation from 1-1-2000 to 12-31-2009 were included in the analysis. Sixty-nine patients were identified, who underwent a total of 85 procedures.</p></div><div><h3>Results</h3><p>The mean age of patients was 66.83 years. We found that 7.25% of the patients had detectable alterations on magnetic resonance imaging. After treatment, 96.47% of patients reported immediate relief. In the long-term follow-up, 62.3% of patients were discharged and were symptom free.</p></div><div><h3>Conclusions</h3><p>In our study, gender, age and pain location were similar to those reported in the literature. In our series, there was no post-operative mortality. Postoperative complications were slightly lower than reported in the literature but this finding may be due to the retrospective nature of our study. Careful clinical investigation and imaging remain essential to trigeminal neuralgia diagnosis. Radiofrequency thermo-coagulation is a safe and effective treatment for patients with this disorder.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 3","pages":"Pages 68-74"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91747297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discurso de contestación por el Dr. José Antonio Iriarte Ezkurdia jose Antonio Iriarte Ezkurdia博士的答辩辞
Gaceta Medica de Bilbao Pub Date : 2011-07-01 DOI: 10.1016/j.gmb.2011.06.004
José Antonio Iriarte-Ezkurdia
{"title":"Discurso de contestación por el Dr. José Antonio Iriarte Ezkurdia","authors":"José Antonio Iriarte-Ezkurdia","doi":"10.1016/j.gmb.2011.06.004","DOIUrl":"10.1016/j.gmb.2011.06.004","url":null,"abstract":"","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"108 3","pages":"Pages 94-95"},"PeriodicalIF":0.0,"publicationDate":"2011-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.06.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86559448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信